Stevanato Group S.p.A. (STVN)
- Previous Close
21.58 - Open
21.50 - Bid 18.67 x 800
- Ask 34.96 x 800
- Day's Range
21.50 - 22.57 - 52 Week Range
16.56 - 35.56 - Volume
280,716 - Avg. Volume
576,423 - Market Cap (intraday)
5.97B - Beta (5Y Monthly) 0.58
- PE Ratio (TTM)
42.90 - EPS (TTM)
0.51 - Earnings Date Aug 6, 2024
- Forward Dividend & Yield 0.06 (0.26%)
- Ex-Dividend Date Jun 4, 2024
- 1y Target Est
26.68
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
www.stevanatogroup.com5,635
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: STVN
View MorePerformance Overview: STVN
Trailing total returns as of 8/30/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: STVN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: STVN
View MoreValuation Measures
Market Cap
5.97B
Enterprise Value
6.23B
Trailing P/E
42.76
Forward P/E
41.67
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.83
Price/Book (mrq)
4.79
Enterprise Value/Revenue
5.17
Enterprise Value/EBITDA
22.31
Financial Highlights
Profitability and Income Statement
Profit Margin
11.27%
Return on Assets (ttm)
5.30%
Return on Equity (ttm)
10.31%
Revenue (ttm)
1.09B
Net Income Avi to Common (ttm)
122.56M
Diluted EPS (ttm)
0.51
Balance Sheet and Cash Flow
Total Cash (mrq)
80.12M
Total Debt/Equity (mrq)
24.09%
Levered Free Cash Flow (ttm)
-355.25M